ROFERON (RIFN-ALPHA(2A)) IS MORE IMMUNOGENIC THAN INTRON-A (RIFN-ALPHA(2B)) IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA

被引：30
|
作者：
VONWUSSOW, P
HEHLMANN, R
HOCHHAUS, T
JAKSCHIES, D
NOLTE, KU
PRUMMER, O
ANSARI, H
HASFORD, J
HEIMPEL, H
DEICHER, H
机构：
[1] UNIV HEIDELBERG, HOSP MED 3, DEPT HAEMATOL, D-69115 HEIDELBERG, GERMANY
[2] BIOMETR CTR THERAPEUT STUDIES, W-8000 MUNICH, GERMANY
[3] UNIV ULM, DEPT HAEMATOL ONCOL, W-7900 ULM, GERMANY
来源：
JOURNAL OF INTERFERON RESEARCH | 1994年 / 14卷 / 04期
关键词：
D O I：
10.1089/jir.1994.14.217
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：217 / 219
页数：3
相关论文
共 50 条
  • [1] RIFN-ALPHA-2A (ROFERON) IS MORE IMMUNOGENIC THAN RIFN-ALPHA-2B (INTRON-A) IN PATIENTS WITH CML
    VONWUSSOW, P
    HEHLMANN, R
    NOLTE, KU
    JAKSCHIES, D
    HOCHHAUS, T
    WITTE, T
    ANSARI, H
    HASFORD, J
    PRUMMER, O
    HEIMPEL, H
    DEICHER, H
    [J]. BLOOD, 1993, 82 (10) : A378 - A378
  • [2] NATURAL IFN-ALPHA THERAPY IN RIFN-ALPHA 2B RESISTANT PATIENTS
    VONWUSSOW, P
    HARTMANN, F
    FREUND, M
    POLIWODA, H
    DEICHER, H
    [J]. BLUT, 1988, 57 (04): : 223 - 223
  • [3] ANTIPROLIFERATIVE EFFECT OF RECOMBINANT ALPHA (RIFN-ALPHA) AND GAMMA (RIFN-GAMMA) INTERFERONS IN MYELOGENOUS LEUKEMIA-CELL LINES
    BERAN, M
    ROSENBLUM, M
    ANDERSSON, B
    MCCREDIE, KB
    GUTTERMAN, J
    HESTER, J
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 281 - 281
  • [4] TREATMENT OF CHRONIC NON-A, NON-B HEPATITIS WITH HIGH-DOSES OF RIFN-ALPHA OR RIFN-GAMMA
    SAEZROYUELA, F
    PORRES, JC
    CARRENO, V
    [J]. HEPATOLOGY, 1989, 10 (04) : 646 - 646
  • [5] EFFECT OF INTERFERONS (RIFN-ALPHA 2, RIFN-GAMMA) ON DNA-SYNTHESIS AND HLA-DR EXPRESSION IN PSORIASIS
    SCHULZE, HJ
    MAHRLE, G
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1986, 278 (05) : 416 - 418
  • [6] LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-C PATIENTS, NONRESPONDERS TO RECOMBINANT INTERFERON-ALPHA (RIFN-ALPHA)
    CIMINO, L
    CITARELLA, C
    NARDONE, G
    BUDILLON, G
    [J]. JOURNAL OF HEPATOLOGY, 1992, 14 (2-3) : 419 - 420
  • [7] PROLONGED RIFN-ALPHA THERAPY (18 MONTHS) OF CHRONIC NON-A, NON-B HEPATITIS
    GOMEZRUBIO, M
    PORRES, JC
    CARRENO, V
    [J]. HEPATOLOGY, 1989, 10 (04) : 692 - 692
  • [8] POSTTREATMENT FOLLOW-UP OF PATIENTS WITH CHRONIC HEPATITIS-B ON RIFN-ALPHA THERAPY - COMPARISON WITH A CONTROL-GROUP
    ZAMORA, L
    PORRES, JC
    BARTOLOME, J
    CARRENO, V
    [J]. HEPATOLOGY, 1989, 10 (04) : 699 - 699
  • [9] B-CELL MATURATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA .2. CLONAL HETEROGENEITY IN THE RESPONSE TO VARIOUS B-CELL ACTIVATORS AND RECOMBINANT CYTOKINES (RIFN-GAMMA,RIFN-ALPHA,RIL-2)
    PFEFFER, K
    NERL, C
    KABELITZ, D
    [J]. IMMUNOBIOLOGY, 1987, 175 (03) : 172 - 182
  • [10] PRECLINICAL MODELS IN ONCOLOGY AND DEVELOPMENT OF COMBINATION CYTOKINE THERAPY INCLUDING RIL-2 AND RIFN-ALPHA
    TRUITT, GA
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 313 - 313
12345